secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2024-10-15T23:59:59+00:00
Accession:  0001493152-24-041036
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD establishes Miami global HQ; anticipates U.S. launch of CGuard Prime in H1 2025
--------------------------------------------------------------------------------

- New global headquarters in Miami, Florida to support anticipated U.S. launch of CGuard Prime carotid stent system.
- Company expects potential FDA approval and U.S. launch in first half of 2025.
- Lease for 10,782 sq ft office space with 64-month term; $500,000 security deposit.
- Building commercial teams and infrastructure to support U.S. market.
- Submitted final module of PMA to FDA on September 16, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315224041036/0001493152-24-041036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315224041036/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-041036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer